<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recent studies suggest that <z:chebi fb="0" ids="4653">dipyridamole</z:chebi> (DP) may exert <z:hpo ids='HP_0001297'>stroke</z:hpo> protective effects beyond platelet inhibition </plain></SENT>
<SENT sid="1" pm="."><plain>The purpose of this study is to determine whether <z:chebi fb="0" ids="35664">statin</z:chebi> and DP could enhance <z:hpo ids='HP_0001297'>stroke</z:hpo> protection through nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO)-dependent vascular effects </plain></SENT>
<SENT sid="2" pm="."><plain>Mice were pretreated with DP (10 to 60 mg/kg, q 12 h, 3 days) alone or in combination with a <z:chebi fb="0" ids="35664">statin</z:chebi> (<z:chebi fb="0" ids="9150">simvastatin</z:chebi>; 0.1 to 20 mg/kg per day, 14 days) before transient intraluminal middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Although <z:chebi fb="0" ids="9150">simvastatin</z:chebi> (1 mg/kg per day, 14 days) increased endothelial NO synthase (eNOS) activity by 25% and DP (30 mg/kg, q12 h, 3 days) increased aortic cGMP levels by 55%, neither <z:chebi fb="0" ids="35664">statin</z:chebi> nor DP alone, at these subtherapeutic doses, increased absolute cerebral blood flow (CBF) or conferred <z:hpo ids='HP_0001297'>stroke</z:hpo> protection </plain></SENT>
<SENT sid="4" pm="."><plain>However, the combination of subtherapeutic doses of <z:chebi fb="0" ids="9150">simvastatin</z:chebi> and DP increased CBF by 50%, decreased <z:hpo ids='HP_0001297'>stroke</z:hpo> volume by 54%, and improved neurologic motor deficits, <z:hpo ids='HP_0000001'>all</z:hpo> of which were absent in eNOS-deficient mice </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast, treatment with aspirin (10 mg/kg per day, 3 days) did not augment the neuroprotective effects of DP and/or <z:chebi fb="0" ids="9150">simvastatin</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>These findings indicate that <z:chebi fb="0" ids="35664">statin</z:chebi> and DP exert additive NO-dependent vascular effects and suggest that the combination of <z:chebi fb="0" ids="35664">statin</z:chebi> and DP has greater benefits in <z:hpo ids='HP_0001297'>stroke</z:hpo> protection than <z:chebi fb="0" ids="35664">statin</z:chebi> alone through vascular protection </plain></SENT>
</text></document>